GSK1059615

GSK1059615

CAT N°: 11569
Price:

From 140.00 119.00

PI 3-kinase ? (PI3K?) is a critical regulator of cell growth and transformation. Its signaling pathway is the most commonly mutated pathway in human cancers. GSK1059615 is a potent, reversible, ATP-competitive, thiazolidinedione inhibitor of PI3K? (IC50 = 2 nM) and the common activating mutants of p110? (E542K, E545K, and H1047R) found in cancer.{20675,20676} It prevents proliferation in BT474 tumor xenografts and reduces MAPK signaling following twice daily dosing at 25 mg/kg.{20675}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 5Z-[[4-(4-pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidinedione
  • Correlated keywords
    • Phosphatidylinositols PI 3-kinases ? PI3Ks PI3K? PI3Ka PI3K.alpha. inhibits inhibitors inhibition thiazolidinediones cells growth human cancers ATP-competitive p110? p110.alpha. p110a E542K E545K H1047R BT474 tumors xenografts MAPKs signaling biology signals transductions 1356195-42-0 1497419-94-9 GSK 1059615 GSK-615
  • Product Overview:
    PI 3-kinase ? (PI3K?) is a critical regulator of cell growth and transformation. Its signaling pathway is the most commonly mutated pathway in human cancers. GSK1059615 is a potent, reversible, ATP-competitive, thiazolidinedione inhibitor of PI3K? (IC50 = 2 nM) and the common activating mutants of p110? (E542K, E545K, and H1047R) found in cancer.{20675,20676} It prevents proliferation in BT474 tumor xenografts and reduces MAPK signaling following twice daily dosing at 25 mg/kg.{20675}

We also advise you